HopeStage
Back to all studies
RecruitingNCT06824532

Veterans’ views of ketamine-assisted therapy for depression and end-of-life care

About this titleRead the official source — NCT06824532
Observational studyAges 65+United States
The study in practice

Understand this study

Who could participate?

Listed age limits: from 65 years.

Listed locations
AlbanySee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 8, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
30
Sponsor
Albany Research Institute, Inc.
Sponsor type
Research institute
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United States
Age range
Over 65 Years
Official registry ID
NCT06824532
Official title
Show the full official title

Veteran's Perceptions of Ketamine-Assisted Psychotherapy (KAP) for Depression and End-of-Life

Recruitment & locations

Currently recruiting

Albany

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Albany Research Institute, Inc., a research institute.

Who can participate?

Listed age limits: from 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies